Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation

Journal of Leukocyte Biology

Volumn 80, Issue 2, 2006, Pages 247-257

  Zittermann, Sandra I ^a   Issekutz, Andrew C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adhesion molecule; Chemokine; Inflammatory mediator

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CAM MONOCLONAL ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SKIN BLOOD VESSEL; SKIN DEFECT; SKIN INFLAMMATION; STIMULUS RESPONSE; TISSUE WATER; ANIMAL; BLOOD; CAPILLARY PERMEABILITY; CHEMOTAXIS; DERMATITIS; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; LEWIS RAT;

ANIMALS; CAPILLARY PERMEABILITY; CHEMOTAXIS; DERMATITIS; DRUG SYNERGISM; FIBROBLAST GROWTH FACTORS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; MALE; MONOCYTES; NEUTROPHIL INFILTRATION; P-SELECTIN; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748867954     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1205718     Document Type: Article

References (54)

1. Springer, T. A. (1995) Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57, 827-872.
2. Pintavorn, P., Ballermann, B. J. (1997) TGF-β and the endothelium during immune injury. Kidney Int. 51, 1401-1412.
3. Lee, T. H., Avraham, H., Lee, S. H., Avraham, S. (2002) Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 277, 10445-10451.
4. Tromp, S. C., oude Egbrink, M. G., Dings, R. P., van Velzen, S., Slaaf, D. W., Hillen, H. F., Tangelder, G. J., Reneman, R. S., Griffioen, A. W. (2000) Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol. 12, 671-676.
5. Ferrara, N., Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25.
6. Griffioen, A. W., Molema, G. (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237-268.
7. Manabe, N., Oda, H., Nakamura, K., Kuga, Y., Uchida, S., Kawaguchi, H. (1999) Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology (Oxford) 38, 714-720.
8. Kikuchi, K., Hoashi, T., Kanazawa, S., Tamaki, K. (2005) Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa. J. Am. Acad. Dermatol. 53, 57-61.
9. Redington, A. E., Roche, W. R., Madden, J., Frew, A. J., Djukanovic, R., Holgate, S. T., Howarth, P. H. (2001) Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J. Allergy Clin. Immunol. 107, 384-387.
10. Weis, S. M., Cheresh, D. A. (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437, 497-504.
11. Detmar, M., Brown, L. F., Berse, B., Jackman, R. W., Elicker, B. M., Dvorak, H. F., Claffey, K. P. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108, 263-268.
12. Sandner, P., Wolf, K., Bergmaier, U., Gess, B., Kurtz, A. (1997) Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int. 51, 448-453.
13. Alagappan, V. K., McKay, S., Widyastuti, A., Garrelds, I. M., Bogers, A. J., Hoogsteden, H. C., Hirst, S. J., Sharma, H. S. (2005) Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochem. Biophys. 43, 119-129.
14. Pages, G., Pouyssegur, J. (2005) Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc. Res. 65, 564-573.
15. Bikfalvi, A., Klein, S., Pintucci, G., Rifkin, D. B. (1997) Biological roles of fibroblast growth factor-2. Endocr. Rev. 18, 26-45.
16. Detmar, M., Brown, L. F., Schon, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., Jain, R. K. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6.
17. Dirkx, A. E., Oude Egbrink, M. G., Kuijpers, M. J., van der Niet, S. T., Heijnen, V. V., Bouma-ter Steege, J. C., Wagstaff, J., Griffioen, A. W. (2003) Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 63, 2322-2329.
18. Griffioen, A. W., Damen, C. A., Blijham, G. H., Groenewegen, G. (1996) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88, 667-673.
19. Zhang, H., Issekutz, A. C. (2002) Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Am. J. Pathol. 160, 2219-2230.
20. Reinders, M. E., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., Briscoe, D. M. (2003) Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J. Clin. Invest. 112, 1655-1665.
21. Kanazawa, S., Tsunoda, T., Onuma, E., Majima, T., Kagiyama, M., Kikuchi, K. (2001) VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am. J. Gastroenterol. 96, 822-828.
22. Zittermann, S. I., Issekutz, A. C. (2006) Basic fibroblast growth factor (bFGF; FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am. J. Pathol. 168, 835-846.
23. Belgore, F., Lip, G. Y., Blann, A. D. (2003) Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur. J. Clin. Invest. 33, 833-839.
24. Issekutz, A. C., Issekutz, T. B. (1993) Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 α, tumor necrosis factor-α, and IFN-γ. J. Immunol. 151, 2105-2115.
25. Walter, U. M., Ayer, L. M., Wolitzky, B. A., Wagner, D. D., Hynes, R. O., Manning, A. M., Issekutz, A. C. (1997) Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in the P-selectin-deficient mouse. Hybridoma 16, 249-257.
26. Walter, U. M., Ayer, L. M., Manning, A. M., Frenette, P. S., Wagner, D. D., Hynes, R. O., Wolitzky, B. A., Issekutz, A. C. (1997) Generation and characterization of a novel adhesion function blocking monoclonal antibody recognizing both rat and mouse E-selectin. Hybridoma 16, 355-361.
27. May, M. J., Entwistle, G., Humphries, M. J., Ager, A. (1993) VCAM-1 is a CS1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium. J. Cell Sci. 106, 109-119.
28. Tamatani, T., Miyasaka, M. (1990) Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. 2, 165-171.
29. Tamatani, T., Kotani, M., Miyasaka, M. (1991) Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur. J. Immunol. 21, 627-633.
30. Issekutz, T. B., Wykretowicz, A. (1991) Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine-stimulated endothelium in the rat. J. Immunol. 147, 109-116.
31. Udaka, K., Takeuchi, Y., Movat, H. Z. (1970) Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133, 1384-1387.
32. Issekutz, A. C. (1981) Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration. Lab. Invest. 45, 435-441.
33. Issekutz, T. B. (1992) Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J. Immunol. 149, 3394-3402.
34. Issekutz, T. B. (1995) In vivo blood monocyte migration to acute inflammatory reactions, IL-1 α, TNF-α, IFN-γ, and C5a utilizes LFA-1, Mac-1, and VLA-4. The relative importance of each integrin. J. Immunol. 154, 6533-6540.
35. Issekutz, T. B., Miyasaka, M., Issekutz, A. C. (1996) Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J. Exp. Med. 183, 2175-2184.
36. Marshall, D., Haskard, D. O. (2003) Quantifying inflammation in vivo using radiolabeled antibodies and leukocytes. Methods Mol. Biol. 225, 273-282.
37. Issekutz, A. C., Issekutz, T. B. (2002) The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J. Immunol. 168, 1934-1939.
38. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
39. Watanabe, H., Mamelak, A. J., Wang, B., Howell, B. G., Freed, I., Esche, C., Nakayama, M., Nagasaki, G., Hicklin, D. J., Kerbel, R. S., Sauder, D. N. (2004) Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity. Exp. Dermatol. 13, 671-681.
40. Yamashita, A., Yonemitsu, Y., Okano, S., Nakagawa, K., Nakashima, Y., Irisa, T., Iwamoto, Y., Nagai, Y., Hasegawa, M., Sueishi, K. (2002) Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J. Immunol. 168, 450-457.
41. Issekutz, A. C. (1981) Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo. Lab. Invest. 45, 234-240.
42. Pasieka, Z., Stepien, H., Komorowski, J., Kolomecki, K., Kuzdak, K. (2003) Evaluation of the levels of bFGF, VEGF, sICAM-1, and sVCAM-1 in serum of patients with thyroid cancer. Recent Results Cancer Res. 162, 189-194.
43. Guo, Z. H., Mei, H., Huang, J., Li, S. Y. (2003) Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma. Ai Zheng 22, 307-309.
44. Usui, T., Ishida, S., Yamashiro, K., Kaji, Y., Poulaki, V., Moore, J., Moore, T., Amano, S., Horikawa, Y., Dartt, D., Golding, M., Shima, D. T., Adamis, A. P. (2004) VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 45, 368-374.
45. Croll, S. D., Ransohoff, R. M., Cai, N., Zhang, Q., Martin, F. J., Wei, T., Kasselman, L. J., Kintner, J., Murphy, A. J., Yancopoulos, G. D., Wiegand, S. J. (2004) VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 187, 388-402.
46. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., Koh, G. Y. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κ B activation in endothelial cells. J. Biol. Chem. 276, 7614-7620.
47. Radisavljevic, Z., Avraham, H., Avraham, S. (2000) Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J. Biol. Chem. 275, 20770-20774.
48. Chuluyan, H. E., Issekutz, A. C. (1993) The VLA-4 integrin can mediate CD11/CD18 independent transendothelial migration of human monocytes. J. Clin. Invest. 92, 2768-2777.
49. Chuluyan, H. E., Osborn, L., Lobb, R., Issekutz, A. C. (1995) Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. J. Immunol. 155, 3135-3144.
50. Issekutz, A. C., Issekutz, T. B. (1995) Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J. Exp. Med. 181, 1197-1203.
51. Meerschaert, J., Furie, M. B. (1994) Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J. Immunol. 152, 1915-1926.
52. Zhang, H., Issekutz, A. C. (2001) Growth factor regulation of neutrophil-endothelial cell interactions. J. Leukoc. Biol. 70, 225-232.
53. Marumo, T., Schini-Kerth, V. B., Busse, R. (1999) Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131-1137.
54. Paludan, S. R. (2000) Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J. Leukoc. Biol. 67, 18-25.